Inflammation has been associated with recurrent stroke risk through mechanisms involving atherosclerosis, atrial cardiopathy, blood–brain barrier dysfunction and biomarkers such as interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hsCRP) which are proposed to identify patients at increased vascular risk (1). The gene discussed is IL6; the disease is Stroke.